Zanubrutinib
Update Venetoclax in CLL
Obinutuzumab
(Update) Acalabrutinib in CLL and MCL
NCCN Guidelines for Patients
ASH: COVID-19 Resources for Managing Blood Cancers
Patient Power
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL